| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $48.4M | +26.8% |
| Cost of Revenue | $42.5M | +24.8% |
| Gross Profit | $5.9M | +43.3% |
| R&D Expense | $25.6M | +14.8% |
| SG&A Expense | $33.8M | -17.2% |
| Operating Income | -$62.6M | -6.2% |
| Income Tax | $0 | — |
| Net Income | -$94.4M | +21.3% |
| EPS (Basic) | -$5.61 | +60.3% |
| EPS (Diluted) | -$5.61 | +60.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.2M | +351.8% |
| Accounts Receivable | $2.2M | -3.5% |
| Inventory | $7.4M | +8.9% |
| Current Assets | $22.0M | +17.0% |
| Total Assets | $410.5M | -4.1% |
| Current Liabilities | $16.3M | -70.6% |
| Long-term Debt | $483.1M | +10.6% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.3M | -12.1% |
| Capital Expenditures | $11.6M | -85.9% |
| Investing Cash Flow | -$11.6M | +85.9% |
| Financing Cash Flow | $45.2M | -54.9% |
| Free Cash Flow | -$41.9M | +61.7% |
| $576.7M |
| +9.1% |
| Stockholders' Equity | -$166.2M | -65.4% |